Company Filing History:
Years Active: 2011
Title: Innovations of Shawn A. Defrees in Neuroprotection and Cancer Treatment.
Introduction
Shawn A. Defrees is an accomplished inventor based in North Wales, Pennsylvania. He has made significant contributions to the field of neuroprotection and cancer treatment through his innovative work in synthetic glycosphingolipids.
Latest Patents
Shawn A. Defrees holds a patent for "Ganglioside compositions and methods of use." This patent describes novel synthetic glycosphingolipids and pharmaceutical compositions that contain these synthetic compounds. The patent also outlines methods for creating these novel synthetic glycosphingolipid compounds and their applications in neuroprotection and cancer treatment.
Career Highlights
Shawn A. Defrees is associated with Seneb Biosciences, Inc., where he continues to advance research in his field. His work focuses on developing innovative solutions that can potentially improve treatment outcomes for patients suffering from neurological disorders and cancer.
Collaborations
Some of his notable coworkers include Karl Frank Johnson and Zhi-Guang Wang, who contribute to the collaborative efforts at Seneb Biosciences, Inc. Their combined expertise enhances the research and development initiatives within the company.
Conclusion
Shawn A. Defrees exemplifies the spirit of innovation in the medical field, particularly in neuroprotection and cancer treatment. His contributions through patents and collaboration with other experts highlight the importance of research in developing effective therapies.